<DOC>
	<DOC>NCT00565396</DOC>
	<brief_summary>The purpose of this study is to determine whether fosinopril and losartan are effective in the treatment of patients with Chronic Kidney Disease(CKD) stage 3.</brief_summary>
	<brief_title>Effectiveness Study on Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<mesh_term>Proteinuria</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<mesh_term>Fosinopril</mesh_term>
	<criteria>Patients aged 1875 years old Roll out secondary renal diseases Do not use steroids and immunosuppresive drugs ACEI/ARB treated patients should have 714 days wash out periodï¼ŒSiDBP&lt; 110mmHg Willing and able to comprehend and give written informed consent Willing to followup regularly Use steroids and immunosuppresive drugs Secondary renal diseases Acute cardiocerebral diseases within 6 months Post renal transplantation Pregnant/Nursing women History of hypersensitivity to ACEI/ARB Refuse to join clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2007</verification_date>
</DOC>